BUY MBP LAPATINIB HERDUO 250MG 150 TAB BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Lapatinib is an oral anticancer medicine used mainly to treat certain types of breast cancer that overexpress a protein called HER2. It is most commonly used in patients with advanced or metastatic breast cancer, particularly when the cancer has stopped responding to other treatments such as trastuzumab. Lapatinib is usually given in combination with other medicines such as capecitabine or letrozole, depending on the type and stage of cancer.

Lapatinib works by blocking specific proteins on the surface of cancer cells known as tyrosine kinases, particularly HER2 and EGFR. These proteins send signals that tell cancer cells to grow, divide, and survive. By blocking these signals, lapatinib slows or stops the growth of cancer cells and can help reduce tumour progression. Unlike some other treatments, lapatinib works inside the cell, which allows it to be effective even when cancer has become resistant to certain other HER2-targeted therapies.

Lapatinib is taken by mouth, usually once daily. It must be taken on an empty stomach, either at least one hour before food or at least one hour after eating. Taking it with food can significantly increase the amount of drug absorbed, which may increase the risk of side effects. It is important to take lapatinib at the same time each day and to swallow the tablets whole with water. Doses should not be missed, crushed, or split.

Treatment with lapatinib is usually long term and continues as long as the cancer is responding and side effects remain manageable. Regular monitoring is required to assess response to treatment and to detect any potential complications early.

Common side effects of lapatinib include diarrhoea, nausea, vomiting, loss of appetite, fatigue, and skin reactions such as rash, dryness, or itching. Diarrhoea is one of the most frequent side effects and should be managed early with fluids and anti-diarrhoeal medication to prevent dehydration. Skin reactions are usually mild to moderate and may improve with moisturisers or topical treatments.

Lapatinib can also affect the heart, particularly the heart?s pumping ability. For this reason, heart function may be monitored before and during treatment using tests such as an echocardiogram. Symptoms such as shortness of breath, swelling of the legs, chest discomfort, or unexplained fatigue should be reported promptly.

Liver function can also be affected by lapatinib. Blood tests are performed regularly to monitor liver enzymes. Signs of liver problems may include yellowing of the skin or eyes, dark urine, abdominal pain, or persistent nausea, and these require immediate medical attention.

Less commonly, lapatinib may cause lung inflammation, which can present as cough, shortness of breath, or chest tightness. This is rare but potentially serious and should be evaluated urgently if symptoms occur.

Lapatinib can interact with many other medications, especially those that affect liver enzymes. Certain antibiotics, antifungal medicines, seizure medications, and herbal supplements such as St John?s wort can reduce its effectiveness or increase side effects. It is important to inform healthcare providers of all medicines and supplements being used.

Lapatinib should not be used during pregnancy, as it may harm an unborn baby. Effective contraception is required during treatment and for a period after stopping the medication. Breastfeeding is not recommended while taking lapatinib.

Although lapatinib does not cure cancer, it can significantly slow disease progression and improve quality of life for many patients with HER2-positive breast cancer. With careful monitoring, proper adherence, and supportive care, lapatinib can be an important and effective part of long-term cancer treatment.